先端医科学研究所

Medicine & Life Sciences

1. Adenocarcinoma 9%
2. Adenocarcinoma of Lung 12%
3. Amino Acid Transport System X-AG 10%
4. Antibodies 18%
5. Antigens 31%
6. Apoptosis 12%
7. Astrocytes 31%
8. Biomarkers 10%
9. Brain 33%
10. Brain Neoplasms 16%
11. Breast Neoplasms 13%
12. Cadherins 11%
13. Cancer Vaccines 10%
14. Cancer-Associated Fibroblasts 9%
15. Carcinogenesis 18%
16. Catenins 9%
17. Cell Line 24%
18. Cell Proliferation 11%
19. Cell Survival 9%
20. Channelrhodopsins 12%
21. Cholangiocarcinoma 16%
22. Cisplatin 11%
23. Colonic Neoplasms 11%
24. Colorectal Neoplasms 11%
25. Complementary DNA 11%
26. Corpus Striatum 11%
27. Cystine 9%
28. Cytokines 10%
29. Cytotoxic T-Lymphocytes 14%
30. Demyelinating Diseases 9%
31. Dendritic Cells 18%
32. Dorsal Raphe Nucleus 14%
33. Down-Regulation 14%
34. Epithelial Cell Adhesion Molecule 12%
35. Epithelial Cells 11%
36. Epithelial-Mesenchymal Transition 24%
37. Epitopes 26%
38. Fibroblasts 13%
39. Forensic Anthropology 13%
40. Gene Expression 13%
41. Genes 28%
42. Glioblastoma 28%
43. Glioma 65%
44. Glutathione 9%
45. gp100 Melanoma Antigen 12%
46. Graft vs Host Disease 24%
47. Growth 20%
48. HLA Antigens 11%
49. HLA-A2 Antigen 26%
50. HLA-A24 Antigen 16%
51. Idiopathic Thrombocytopenic Purpura 13%
52. Immunosuppressive Agents 12%
53. Immunotherapy 54%
54. In Vitro Techniques 14%
55. Induced Pluripotent Stem Cells 14%
56. Interleukin-2 14%
57. Lacrimal Apparatus 16%
58. Ligands 10%
59. MART-1 Antigen 9%
60. Melanocytes 15%
61. Melanoma 81%
62. Melanoma-Specific Antigens 63%
63. Messenger RNA 11%
64. Monophenol Monooxygenase 9%
65. Mutation 12%
66. Nateglinide 9%
67. Neoplasm Antigens 43%
68. Neoplasm Metastasis 25%
69. Neoplasms 100%
70. Neoplastic Stem Cells 70%
71. Neural Stem Cells 17%
72. Neuroglia 18%
73. Neurons 30%
74. Non-Small Cell Lung Carcinoma 9%
75. Oligodendroglia 14%
76. Optogenetics 51%
77. Organoids 9%
78. Osteosarcoma 18%
79. Oxidation-Reduction 12%
80. Oxidative Stress 11%
81. Peptides 24%
82. Phenotype 18%
83. Protein Isoforms 11%
84. Proteins 18%
85. Reactive Oxygen Species 14%
86. Serotonin 15%
87. Serum 10%
88. Squamous Cell Carcinoma of Head and Neck 9%
89. Stem Cells 40%
90. Stomach 12%
91. Stomach Neoplasms 18%
92. Sulfasalazine 25%
93. Survival 11%
94. T-Lymphocyte Epitopes 12%
95. T-Lymphocytes 63%
96. Therapeutics 25%
97. Transgenic Mice 14%
98. Tumor Microenvironment 18%
99. Tumor-Infiltrating Lymphocytes 51%
100. Vaccination 11%